Showing results (131-140 of 243) with videos related to

Sort By:
Pageof 25
Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosusMatthew H Liang, Julia F Simard, Karen Costenbader, et al.
Lupus|May 5, 2025
The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysisSusan Manzi, Jorge Sánchez-Guerrero, Naoto Yokogawa, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic RegistryKathleen Maksimowicz-McKinnon, Faith Selzer, Susan Manzi, et al.
Journal of Scleroderma and Related Disorders|March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working GroupsMurray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
Annals of the Rheumatic Diseases|May 17, 2022
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trialsIan N Bruce, Richard A Furie, Eric F Morand, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trialsEdward M Vital, Joan T Merrill, Eric F Morand, et al.
The Journal of Rheumatology|May 23, 2007
Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosusF Yesim K Demirci, Susan Manzi, Rosalind Ramsey-Goldman, et al.
Arthritis and Rheumatism|February 1, 2006
Platelet C4d is highly specific for systemic lupus erythematosusJeannine S Navratil, Susan Manzi, Amy H Kao, et al.
The American Journal of Cardiology|September 9, 2008
C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritisAmy H Kao, Mary Chester M Wasko, Shanthi Krishnaswami, et al.
Pageof 25